H. Schmidt

1.3k total citations
44 papers, 938 citations indexed

About

H. Schmidt is a scholar working on Clinical Biochemistry, Molecular Biology and Endocrinology, Diabetes and Metabolism. According to data from OpenAlex, H. Schmidt has authored 44 papers receiving a total of 938 indexed citations (citations by other indexed papers that have themselves been cited), including 24 papers in Clinical Biochemistry, 16 papers in Molecular Biology and 9 papers in Endocrinology, Diabetes and Metabolism. Recurrent topics in H. Schmidt's work include Metabolism and Genetic Disorders (24 papers), Diet and metabolism studies (7 papers) and Biochemical and Molecular Research (6 papers). H. Schmidt is often cited by papers focused on Metabolism and Genetic Disorders (24 papers), Diet and metabolism studies (7 papers) and Biochemical and Molecular Research (6 papers). H. Schmidt collaborates with scholars based in Germany, United States and Switzerland. H. Schmidt's co-authors include J. Pietz, André Rupp, Horst Bickel, A. Niederwieser, H.‐Ch. Curtius, M. Viscontini, Peter Burgard, H. J. Bremer, Friedrich Manz and I Smith and has published in prestigious journals such as The Journal of Clinical Endocrinology & Metabolism, Clinica Chimica Acta and European Journal of Endocrinology.

In The Last Decade

H. Schmidt

39 papers receiving 886 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
H. Schmidt Germany 19 586 418 311 122 110 44 938
C. Charlton Mabry United States 14 228 0.4× 317 0.8× 143 0.5× 105 0.9× 75 0.7× 41 777
Naruji Sugiyama Japan 18 1.0k 1.7× 843 2.0× 366 1.2× 237 1.9× 168 1.5× 61 1.4k
Paul G. Moe United States 9 500 0.9× 546 1.3× 63 0.2× 75 0.6× 128 1.2× 16 835
P. Tippett United Kingdom 12 143 0.2× 320 0.8× 142 0.5× 79 0.6× 34 0.3× 32 815
P Dreyfus United States 18 349 0.6× 205 0.5× 169 0.5× 59 0.5× 255 2.3× 57 1.2k
Denis Ikkos Sweden 13 322 0.5× 610 1.5× 247 0.8× 50 0.4× 38 0.3× 27 1.2k
Skadi Beblo Germany 21 598 1.0× 432 1.0× 441 1.4× 210 1.7× 137 1.2× 46 1.1k
D. J. Paulson United States 15 245 0.4× 397 0.9× 218 0.7× 36 0.3× 24 0.2× 23 907
Isabel Ibarra‐González Mexico 16 210 0.4× 415 1.0× 192 0.6× 142 1.2× 54 0.5× 76 784
Sandra C. Van Calcar United States 22 868 1.5× 517 1.2× 572 1.8× 234 1.9× 202 1.8× 27 1.2k

Countries citing papers authored by H. Schmidt

Since Specialization
Citations

This map shows the geographic impact of H. Schmidt's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by H. Schmidt with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites H. Schmidt more than expected).

Fields of papers citing papers by H. Schmidt

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by H. Schmidt. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by H. Schmidt. The network helps show where H. Schmidt may publish in the future.

Co-authorship network of co-authors of H. Schmidt

This figure shows the co-authorship network connecting the top 25 collaborators of H. Schmidt. A scholar is included among the top collaborators of H. Schmidt based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with H. Schmidt. H. Schmidt is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Brozanski, Beverly, et al.. (2023). A quality improvement initiative standardizing the antibiotic treatment and feeding practices in patients with medical necrotizing enterocolitis. Journal of Perinatology. 44(4). 587–593. 1 indexed citations
3.
Baumann, Klaus, et al.. (1998). Long‐chain polyunsaturated fatty acids in plasma and erythrocyte membrane lipids of children with phenylketonuria after controlled linoleic acid intake. Journal of Inherited Metabolic Disease. 21(4). 373–381. 30 indexed citations
4.
Pietz, J., André Rupp, D. Rating, et al.. (1998). Neurological outcome in adult patients with early-treated phenylketonuria. European Journal of Pediatrics. 157(10). 824–830. 98 indexed citations
5.
Schmidt, H., et al.. (1997). Die Behandlung von Patienten mit Thrombosen der Arteria basilaris und Locked-in-Syndrom. Der Nervenarzt. 68(8). 653–658. 9 indexed citations
6.
Burgard, Peter, André Rupp, David Konecki, et al.. (1996). Phenylalanine hydroxylase genotypes, predicted residual enzyme activity and phenotypic parameters of diagnosis and treatment of phenylketonuria. European Journal of Pediatrics. 155(S1). S11–S15. 29 indexed citations
7.
Pietz, J., Uta Meyding‐Lamadé, & H. Schmidt. (1996). Magnetic resonance imaging of the brain in adolescents with phenylketonuria and in one case of 6-pyruvoyl tetrahydropteridine synthase deficiency. European Journal of Pediatrics. 155(S1). S69–S73. 19 indexed citations
8.
Schmidt, H., Peter Burgard, J. Pietz, & André Rupp. (1996). Intelligence and professional career in young adults treated early for phenylketonuria. European Journal of Pediatrics. 155(S1). S97–S100. 23 indexed citations
9.
Schmidt, H.. (1995). Effect of papain on different phases of prenatal ontogenesis in rats. Reproductive Toxicology. 9(1). 49–55. 12 indexed citations
10.
Schaefer, Franz, Peter Burgard, André Rupp, et al.. (1994). Growth and skeletal maturation in children with phenylketonuria. Acta Paediatrica. 83(5). 534–541. 47 indexed citations
11.
Thon, A., E. Heinze, Reinhard W. Holl, et al.. (1992). Development of height and weight in children with diabetes mellitus: Report on two prospective multicentre studies, one cross-sectional, one longitudinal. European Journal of Pediatrics. 151(4). 258–262. 56 indexed citations
12.
Manz, Friedrich & H. Schmidt. (1992). Retrospective approach to explain growth retardation and urolithiasis in a child with long-term nutritional acid loading. Zeitschrift für Ernährungswissenschaft. 31(2). 121–129. 7 indexed citations
13.
Schmidt, H., et al.. (1989). [Aspartylglucosaminuria. Clinical description of 2 German patients].. PubMed. 137(8). 454–7. 2 indexed citations
14.
Blau, Nenad, A. Niederwieser, H.‐Ch. Curtius, et al.. (1989). Prenatal Diagnosis of Atypical Phenylketonuria. Journal of Inherited Metabolic Disease. 12(S2). 295–298. 6 indexed citations
15.
Pietz, J., et al.. (1988). Long-term development of intelligence (IQ) and EEG in 34 children with phenylketonuria treated early. European Journal of Pediatrics. 147(4). 361–367. 22 indexed citations
16.
Schmidt, H., et al.. (1987). Continuation vs discontinuation of low-phenylalanine diet in PKU adolescents. European Journal of Pediatrics. 146(1). A17–A19. 21 indexed citations
17.
Smith, I, et al.. (1978). Effect of stopping low-phenylalanine diet on intellectual progress of children with phenylketonuria.. BMJ. 2(6139). 723–726. 114 indexed citations
18.
Schmidt, H., et al.. (1978). [14C-Glibenclamide concentrations in serum and 14C-glibenclamide urine excretion in diabetic patients with simultaneous determination of blood glucose and insulin (author's transl)].. PubMed. 28(2). 330–7. 7 indexed citations
19.
Manz, Friedrich & H. Schmidt. (1974). ACID-BASE STATUS IN DIETARY TREATMENT OF PHENYLKETONURIA. Pediatric Research. 8(2). 135–135. 26 indexed citations
20.
Schmidt, H., et al.. (1973). Metabolism and mode of action of androgens in target tissue of male rats. IV. Mode of action of 5 alpha-androstane-3,17-dione, 5 alpha-androstane-3 alpha,17 beta-diol and of 5 alpha-androstane-3 beta,17 beta-diol at a cellular level on seminal vesicles and prostates of rats.. PubMed. 73(3). 599–611. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by C. Charlton Mabry Breakdown of academic impact, for papers by Naruji Sugiyama Breakdown of academic impact, for papers by Paul G. Moe Breakdown of academic impact, for papers by P. Tippett Breakdown of academic impact, for papers by P Dreyfus Breakdown of academic impact, for papers by Denis Ikkos Breakdown of academic impact, for papers by Skadi Beblo Breakdown of academic impact, for papers by D. J. Paulson Breakdown of academic impact, for papers by Isabel Ibarra‐González Breakdown of academic impact, for papers by Sandra C. Van Calcar
Rankless by CCL
2026